Caricamento...
Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab
Objective. The aim was to assess the efficacy of rituximab for the cutaneous manifestations of adult DM and JDM. Methods. Patients with refractory adult DM (n = 72) and JDM (n = 48) were treated with rituximab in a randomized placebo-phase-controlled trial [either rituximab early drug (week 0/1) or...
Salvato in:
| Pubblicato in: | Rheumatology (Oxford) |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854037/ https://ncbi.nlm.nih.gov/pubmed/27837048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kew396 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|